Â鶹ŮÓÅ

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • Â鶹ŮÓÅ Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Sep 23 2015

Full Issue

Clinton's Plan To Control Prescription Drug Costs Features Cap On Out-Of-Pocket Expenses

Democratic presidential candidate Hillary Clinton's proposal would also allow Medicare to negotiate lower drug costs and increase federal scrutiny of pharmaceutical company pricing.

With voter fury rising over the high cost of prescription drugs, Hillary Rodham Clinton proposed capping out-of-pocket drug expenses at $250 a month on Tuesday while a rival for the Democratic presidential nomination, Senator Bernie Sanders of Vermont, extolled his own plan and long record for pushing to lower drug costs. While Republican candidates for the White House want to repeal the Affordable Care Act and generally oppose interfering with the drug industry, Mrs. Clinton and Mr. Sanders are competing fiercely with each other to press for greater competition and new regulations to rein in pharmaceutical companies. (Healy and Sanger-Katz, 9/22)

Hillary Clinton, laying out her health-care agenda, is trying to shift the national debate surrounding the divisive Affordable Care Act to focus squarely on rising out-of-pocket costs of care. In Iowa on Tuesday, the Democratic presidential contender put forth ideas to control prescription-drug spending. On Wednesday, she’ll talk about other consumer costs, such as high copayments and deductibles. (Meckler, 9/22)

Hillary Clinton on Tuesday unveiled a plan to rein in prescription drug costs by forcing pharmaceutical companies to reinvest their profits into research and allowing for more generic and imported drugs. The proposal, which she outlined in a speech in Iowa on Tuesday, would also allow Medicare to negotiate lower drug costs and cap out-of-pocket expenses for individuals with chronic health problems. (Przybyla, 9/22)

Clinton’s plan has several moving parts, some aimed at directly curbing profits of pharmaceutical companies and others to give the government a stronger role in constraining drug prices or making lower-priced medicine more available. She would allow Americans to reimport U.S.-made drugs from countries where they tend to be sold at lower prices. She would also allow the Medicare program to negotiate prices with drug manufactures. (Gearan and Goldstein, 9/22)

Hillary Clinton's campaign promise on Tuesday to cap prescription drug costs for U.S. consumers lends weight to efforts by health insurers, doctors' groups and consumers to address skyrocketing prices, industry experts said. Clinton, in the lead among Democratic presidential candidates, unveiled a plan that includes a $250 monthly cap on out-of-pocket costs prescription drugs, allowing the Medicare plan for the elderly to negotiate drug pricing and permitting Americans to purchase drugs from other countries at lower cost. (Berkrot, 9/22)

It's almost an afterthought, but the last two bullet points dangling at the end of Hillary Rodham Clinton's manifesto against high drug prices are its linchpin: She wants to allow the government to flex its muscle and negotiate lower drug prices from pharmaceutical companies. (Johnson, 9/22)

With a new poster child for prescription drug price gouging to swing at, Hillary Clinton unveiled a wide-ranging proposal on Tuesday designed to rein in the skyrocketing drug costs that are draining government budgets and the pocketbooks of many Americans. (Pianin, 9/22)

Hillary Clinton‘s prescription drug proposals are likely to get mixed reactions from the insurance lobby — and drugmakers already have come out swinging. The new head of the America’s Health Insurance Plans industry group said in an interview shortly before Mrs. Clinton’s plans were released that insurers have identified pharmaceutical price surges as a key threat to health costs, and that they plan to continue fighting on the issue. (Radnofsky, 9/22)

The leading pharmaceutical lobbying group is lashing out against Hillary Clinton’s soon-to-be-released plan to combat rising drug prices. The head of the Pharmaceutical Research and Manufacturers of America (PhRMA) released a statement Tuesday rebuking her proposals, which he warned would kill jobs, risk patient safety and halt investment in new cures for diseases such as Alzheimer’s, Parkinson’s and cancer. (Ferris, 922)

In other news from the campaign trail -

Vice President Joe Biden surged in a new national Bloomberg Politics poll of Democratic voters and independent voters leaning toward the Democratic Party released Wednesday morning, even though he has not announced his intentions for the presidency. Hillary Clinton earned a plurality of 33 percent, followed by Biden at 25 percent and independent Vermont Sen. Bernie Sanders at 24 percent. Other candidates are polling within the margin of error. (Gass, 9/23)

It looks like John Kasich got himself a new campaign donor last night. The Ohio governor had a tame appearance last night on NBC's "Late Night with Seth Meyers," getting a chance to explain his positions on the economy, faith, Medicaid expansion and debate strategy. (Thompson, 9/23)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 Â鶹ŮÓÅ